Literature DB >> 23690433

Antegrade rapid prime displacement in elective coronary artery surgery is associated with lower perioperative blood transfusions and a shorter hospital stay.

Priyadharshanan Ariyaratnam1, Robert T Bennett, Lindsay A McLean, Kishore K Jagannadham, Edward Turner, Steven Griffin, Mubarak A Chaudhry, Mahmoud Loubani.   

Abstract

OBJECTIVES: Haemodilution during cardiopulmonary bypass is associated with increased perioperative blood transfusions and is thought to reduce intraoperative oxygen delivery to the brain. We sought to evaluate our method of rapid antegrade prime displacement in the context of the perioperative blood transfusion rate, intraoperative cerebral saturations and postoperative hospital stay.
METHODS: Retrospective analysis of 160 propensity-matched patients undergoing elective coronary artery bypass grafting was performed comparing different perfusion strategies on perioperative blood transfusion and length of postoperative stay. Eighty patients who had rapid antegrade prime displacement and vacuum-assisted venous drainage (RAD-VAD) were compared with 80 patients who had conventional cardiopulmonary bypass with gravity drainage (CB). RAD-VAD involved displacing all or most of the prime in the circuit with the patient's own blood prior to the initiation of cardiopulmonary bypass within a 15-20 s window. Within each group, 10 patients had intraoperative cerebral saturation measurements.
RESULTS: There were no differences in the baseline characteristics between the groups. Both groups had a significant fall (P < 0.05) in haematocrit during cardiopulmonary bypass from preoperative values, however, the fall in haematocrit was significantly less in the RAD-VAD group (P < 0.05). There was significantly (P < 0.05) less intraoperative and postoperative homologous blood transfusions in the RAD-VAD group (47.892 ml ± 8.14 and 76.58 ml ± 21.58) compared with the CB group (229.06 ml ± 105.03 and 199.91 ml ± 47.13). There was a significant fall in cerebral saturations within both groups (P < 0.05) but it was not significant between the groups. The postoperative stay was significantly (P < 0.05) shorter in the RAD-VAD group compared with the conventional group (7.74 days ± 0.51 vs 10.13 days ± 0.95).
CONCLUSIONS: RAD-VAD is associated with a significantly lower blood transfusion rate perioperatively and shorter hospital stays compared with CB.

Entities:  

Keywords:  Blood transfusion; Cardiopulmonary bypass

Mesh:

Substances:

Year:  2013        PMID: 23690433      PMCID: PMC3745139          DOI: 10.1093/icvts/ivt223

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  11 in total

1.  Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery.

Authors:  Subramaniam Balachandran; Michael H Cross; Sivagnanam Karthikeyan; Anilkumar Mulpur; Stephen D Hansbro; Peter Hobson
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

Review 2.  Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update.

Authors:  Suzanne Kats; Jacques P A M Schönberger; Ruud Brands; Willem Seinen; Wim van Oeveren
Journal:  Eur J Cardiothorac Surg       Date:  2011-04       Impact factor: 4.191

Review 3.  Patient-centered cardiopulmonary bypass concepts.

Authors:  Stephen M Wildhirt
Journal:  Heart Surg Forum       Date:  2009-06       Impact factor: 0.676

4.  Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group.

Authors:  G R DeFoe; C S Ross; E M Olmstead; S D Surgenor; M P Fillinger; R C Groom; R J Forest; J W Pieroni; C S Warren; M E Bogosian; C F Krumholz; C Clark; R A Clough; P W Weldner; S J Lahey; B J Leavitt; C A Marrin; D C Charlesworth; P Marshall; G T O'Connor
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

5.  Near-infrared spectroscopy for monitoring cerebral ischemia during selective cerebral perfusion.

Authors:  Kazumasa Orihashi; Taijiro Sueda; Kenji Okada; Katsuhiko Imai
Journal:  Eur J Cardiothorac Surg       Date:  2004-11       Impact factor: 4.191

6.  Retrograde autologous priming of the cardiopulmonary bypass circuit: safety and impact on postoperative outcomes.

Authors:  Glenn S Murphy; Joseph W Szokol; Martin Nitsun; David A Alspach; Michael J Avram; Jeffery S Vender; Nick DeMuro; William J Hoff
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-01-06       Impact factor: 2.628

7.  Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

Authors:  Gavin J Murphy; Barnaby C Reeves; Chris A Rogers; Syed I A Rizvi; Lucy Culliford; Gianni D Angelini
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

8.  Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed?

Authors:  Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir Shah
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

9.  Influence of intraoperative fluid volume on cardiopulmonary bypass hematocrit and blood transfusions in coronary artery bypass surgery.

Authors:  Jeffrey A Campbell; David W Holt; Valerie K Shostrom; Samuel J Durham
Journal:  J Extra Corpor Technol       Date:  2008-06

10.  The effect of cardiopulmonary bypass prime volume on the need for blood transfusion after pediatric cardiac surgery.

Authors:  Marc E Richmond; Kevin Charette; Jonathan M Chen; Jan M Quaegebeur; Emile Bacha
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-03       Impact factor: 5.209

View more
  1 in total

1.  The Effect of Standardizing Autologous Prime Techniques in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Alfred H Stammers; Stephen Francis; Eric A Tesdahl; Randi Miller; Anthony Nostro; Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.